mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.7 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |